<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chi L</submitter><funding>NIEHS NIH HHS</funding><pagination>97002</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6792374</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>127(9)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Arsenic-induced liver X receptor/retinoid X receptor (LXR/RXR) signaling inhibition is a potential mechanism underlying the cardiovascular effects caused by arsenic. The gut microbiota can influence arsenic toxic effects.&lt;h4>Objective&lt;/h4>We aimed to explore whether gut microbiota play a role in arsenic-induced LXR/RXR signaling inhibition and the subsequent lipid and cholesterol dysbiosis.&lt;h4>Methods&lt;/h4>Conventional and antibiotic-treated mice (AB-treated mice) were exposed to 0.25 ppm and 1 ppm arsenic for 2 wk. Hepatic mRNAs were extracted and sequenced. The expression levels of genes associated with LXR/RXR signaling were quantified by quantitative real-time polymerase chain reaction (qPCR), and serum and hepatic cholesterol levels were measured. Liquid chromatograp</pubmed_abstract><journal>Environmental health perspectives</journal><pubmed_title>Lipid and Cholesterol Homeostasis after Arsenic Exposure and Antibiotic Treatment in Mice: Potential Role of the Microbiota.</pubmed_title><pmcid>PMC6792374</pmcid><funding_grant_id>P30 ES010126</funding_grant_id><pubmed_authors>Chi L</pubmed_authors><pubmed_authors>Lu K</pubmed_authors><pubmed_authors>Lai Y</pubmed_authors><pubmed_authors>Liu CW</pubmed_authors><pubmed_authors>Tu P</pubmed_authors><pubmed_authors>Xue J</pubmed_authors><pubmed_authors>Ru H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Lipid and Cholesterol Homeostasis after Arsenic Exposure and Antibiotic Treatment in Mice: Potential Role of the Microbiota.</name><description>&lt;h4>Background&lt;/h4>Arsenic-induced liver X receptor/retinoid X receptor (LXR/RXR) signaling inhibition is a potential mechanism underlying the cardiovascular effects caused by arsenic. The gut microbiota can influence arsenic toxic effects.&lt;h4>Objective&lt;/h4>We aimed to explore whether gut microbiota play a role in arsenic-induced LXR/RXR signaling inhibition and the subsequent lipid and cholesterol dysbiosis.&lt;h4>Methods&lt;/h4>Conventional and antibiotic-treated mice (AB-treated mice) were exposed to 0.25 ppm and 1 ppm arsenic for 2 wk. Hepatic mRNAs were extracted and sequenced. The expression levels of genes associated with LXR/RXR signaling were quantified by quantitative real-time polymerase chain reaction (qPCR), and serum and hepatic cholesterol levels were measured. Liquid chromatograp</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Sep</publication><modification>2025-04-21T23:27:34.874Z</modification><creation>2019-11-13T08:02:34Z</creation></dates><accession>S-EPMC6792374</accession><cross_references><pubmed>31532247</pubmed><doi>10.1289/EHP4415</doi></cross_references></HashMap>